Literature DB >> 24712477

Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.

Noriko Sangu1, Tsuyoshi Shimosato, Hirosato Inoda, Shino Shimada, Keiko Shimojima, Tomohiro Ando, Toshiyuki Yamamoto.   

Abstract

Cherubism is a rare genetic disorder characterized by progressive facial deformity caused by non-neoplastic bone lesions in the mandible and/or the maxilla. Src homology-3 binding protein 2 gene (SH3BP2) has been found to be the responsible gene, with alterations in six amino acids noted in patients with this condition. Recently, mutations in this domain have been found to cause stabilization of SH3BP2 by uncoupling with tankyrase. In this study, we identified a new 2-bp mutation that led to a recurrent amino acid change in a sporadic case of cherubism. Our findings indicate that it is important to understand the pattern of progress in typical cherubism.
© 2013 The Authors. Congenital Anomalies © 2013 Japanese Teratology Society.

Entities:  

Keywords:  SH3BP2; Tankyrase; cherubism; multilocular cystic lesions; mutation

Mesh:

Substances:

Year:  2013        PMID: 24712477     DOI: 10.1111/cga.12013

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  2 in total

1.  Novel ANO5 mutation c.1067G>T (p.C356F) identified by whole genome sequencing in a big family with atypical gnathodiaphyseal dysplasia.

Authors:  Binghui Zeng; Junkun Liao; Hanqing Zhang; Sha Fu; Weixiong Chen; Guokai Pan; Qunxing Li; Weiliang Chen; Soldano Ferrone; Binghao Wu; Sheng Sun; Jiali Hu; Michael Ho-Young Ahn; Zhaoyu Lin; Dongsheng Yu; Zhanpeng Ou; Xinhui Wang; Fengbo Mo; Nasi Huang; James A Hamilton; Jinsong Li; Song Fan
Journal:  Head Neck       Date:  2018-12-15       Impact factor: 3.147

Review 2.  Tankyrases: structure, function and therapeutic implications in cancer.

Authors:  Teemu Haikarainen; Stefan Krauss; Lari Lehtio
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.